- ClinOne, an industry leader in remote clinical trial patient management, announced that CU Healthcare Innovation Fund is the lead investor for its Series-A financing with the first closing of $3.6 million
ClinOne — an industry leader in remote clinical trial patient management — announced that CU Healthcare Innovation Fund is the lead investor for its Series-A financing with the first closing of $3.6 million. This fund is affiliated with the Anschutz Medical Campus in Denver and counts UCHealth and Children’s Hospital Colorado as limited partners.
With the ClinOne and ClinTrialConnect platforms, the company allows pharmaceutical sponsors, research sites, and clinical trial participants to perform and automate key clinical trial operational tasks, including clinical trial recruitment, study execution, compliance, and patient retention from any location worldwide.
ClinOne’s modules span patient recruitment, remote consent (eConsent), patient-reported outcomes and surveys (ePRO), dosing management, and remote vital sign management data collection. And it seamlessly integrates with home healthcare visits and telemedicine video visits.
And ClinOne’s solution and its suite of products were created to improve clinical trial enrollment and remote patient compliance. And the company’s mission is to allow important trial details to be at the fingertips of participating researchers, patients, and caregivers completely remotely. Currently, ClinOne conducts clinical trials in 55 countries across 43 languages.
Key Quotes:
“Through these uncertain times, it is comforting to know that technology exists to allow individuals to participate in clinical trials with minimal physical contact with the research site itself. This funding will allow us to expand our product suite and sales efforts to meet the high demand we are seeing.”
-Rob Bohacs, co-founder and CEO of ClinOne
“Our fund invested in ClinOne as it is clear to us that clinical trial management needs to be both digitized – with new workflow tools that better manage and retain patients, and virtualized – by allowing patients to be managed at home and avoid trips to the hospital/research site whenever possible. This need is especially acute now during the current pandemic, as the FDA’s recent guidelines stipulate. ClinOne’s recent partnership with our portfolio company BioIntelliSense, as an example ,will enable remote patient monitoring to come to clinical trial management in more robust ways.”
-Steven Lindseth, General Partner at the CU Healthcare Innovation Fund
